Non-Opioid Therapy

Austin, Texas, August 20, 2026 Raintree Systems has expanded its agentic artificial intelligence (AI) platform for rehabilitation therapy, introducing...

Summit, New Jersey, August 20, 2026 Vascarta Inc. has announced the initiation of a Phase I clinical study of...

BURLINGTON, Mass., August 18, 2026 Consano Bio, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted...

THOUSAND OAKS, Calif., July 29, 2026 Latigo Biotherapeutics announced that The New England Journal of Medicine (NEJM) has published...

London, UK – July 24, 2026 Persica Pharmaceuticals has presented new scientific analyses supporting the development of its investigational...

CHENGDU, China, July 15, 2026 Kelun-Biotech and Harbour BioMed have announced that China’s National Medical Products Administration (NMPA) has...

MALVERN, Pa., July 15, 2026 MAXONA Pharmaceuticals has received U.S. FDA Investigational New Drug (IND) clearance to initiate a...

SOLANA BEACH, Calif., July 1, 2026 Artelo Biosciences, Inc. announced positive preclinical data demonstrating that its investigational drug candidate...

SASKATOON, Saskatchewan, June 11, 2026 ZYUS Life Sciences Corporation announced a strategic corporate realignment designed to sharpen its focus...

GRÄFELFING, Germany – June 9, 2026 VERTANICAL has achieved a major milestone in chronic pain treatment after receiving Germany’s...